MAIA Biotechnology, Inc.
For the period ended May 24, 2024. Filed Apr 16, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 24, 2024 · Filed Apr 16, 2024
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT
This proxy statement sets forth information relating to the solicitation of proxies by the board of directors of MAIA Biotechnology, Inc. (the “Company”) in connection with the Company’s 2024 Annual Meeting of shareholders or any adjournment or postponement of the Annual Meeting (the “Annual Meeting”). The Annual Meeting will take place on May 24, 2024 at 10:00 a.m., Central Time in a virtual meeting format.
This proxy statement and form of proxy will be sent on or about April 16, 2024, to our shareholders of record as of the close of business on March 28, 2024, the record date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.